Categories: News

Wyser launches AgentikX, India’s first-ever Agentic AI Investment Initiative for Enterprise B2B Startups through its maiden fund

BANGALORE, India, Aug. 5, 2025 /PRNewswire/ — Wyser announces AgentikX, India’s first Agentic AI investment initiative designed to identify, develop and invest in startups disrupting the enterprise landscape. Bold and innovative founders solving customer validated problems can apply effective August 5, 2025, with top 10 startups selected for specialized 5-day AgentikX Primer, intended to accelerate Go To Market strategy. AgentikX Primer focuses on Enterprise Agentic AI startups validating and deepening their understanding of industry white spaces, through direct interaction with CXOs/AI Heads across India and globally.

- Advertisement -

“Wyser was born from a simple conviction: India can design and build cutting-edge Agentic AI products for the world. We back founders who are disrupting legacy systems and reimagining how enterprises operate,” says Satyakam Mohanty, Co-Founder and Managing Partner at Wyser.

- Advertisement -

“We built Wyser to provide catalytic capital to founders building in Enterprise Agentic AI. AgentikX is more than funding, it is the platform to provide foresight, friction and fuel and is a call to action for India to lead, bet early, bet bold and bet together,” says Supria Dhanda, Co-Founder and Managing Partner at Wyser.

- Advertisement -

Applications to the AgentikX Primer will close by August 15, 2025. Successful graduates will have the opportunity to pitch to Wyser for investment consideration.

- Advertisement -

About Wyser

- Advertisement -

Wyser is a VC firm that invests in Agentic AI companies poised to transform enterprises, leveraging India’s AI talent and tech startup ecosystem for global impact. Led by experienced operators Satyakam Mohanty and Supria Dhanda, Wyser focuses on pre-seed to seed-stage startups developing autonomous adaptive systems for enterprise/B2B space. With a target corpus of $25 million, the fund will focus on pre-seed to seed-stage startups developing Agentic AI solutions across various industries.

- Advertisement -

Wyser’s investment strategy targets the evolution from AI 1.0 (static) to AI 2.0 (adaptive) for enterprises transforming to enterprise 5.0. This shift represents a significant opportunity, with Agentic AI expected to contribute $17.1 trillion to the global GDP by 2030.

- Advertisement -

The firm will invest in 20-23 Enterprise Agentic AI companies, with investments ranging from $150,000 to $500,000 per startup, emphasizing a product/platform-first approach. Wyser’s portfolio already includes investments in startups like AquaAirX and Pype, with a strong pipeline that validates the groundswell of Agentic interventions coming out of the Indian startup ecosystem

- Advertisement -

Media Contact:
Supria Dhanda
Co-Founder & Managing Partner
supria@wyser.vc 

- Advertisement -

Photo: https://mma.prnewswire.com/media/2744327/Wyser_Launches_Agentikx.jpg

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/wyser-launches-agentikx-indias-first-ever-agentic-ai-investment-initiative-for-enterprise-b2b-startups-through-its-maiden-fund-302521951.html

- Advertisement -

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

14 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

14 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

14 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

16 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

17 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

17 hours ago